Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,200
Closed -$1.26M 594
2023
Q3
$1.26M Buy
+18,200
New +$1.38M 0.16% 218
2015
Q4
Sell
-583,188
Closed -$22.8M 638
2015
Q3
$22.8M Buy
+583,188
New +$23.1M 0.51% 32
2015
Q2
Sell
-43,117
Closed -$1.42M 1456
2015
Q1
$1.42M Buy
+43,117
New +$1.32M 0.04% 608
2014
Q4
Sell
-107,076
Closed -$2.6M 830
2014
Q3
$2.6M Sell
107,076
-57,369
-35% -$1.45M 0.07% 339
2014
Q2
$4.17M Buy
164,445
+68,794
+72% +$1.61M 0.11% 232
2014
Q1
$2.06M Buy
+95,651
New +$2.06M 0.05% 450
2013
Q4
Sell
-302,630
Closed -$6.25M 857
2013
Q3
$6.25M Buy
302,630
+32,162
+12% +$685K 0.17% 147
2013
Q2
$5.22M Buy
+270,468
New +$5.65M 0.13% 187

Other funds holding HOLX

PDT Partners's HOLX Position: Q4 2023 in Review

PDT Partners sold out of Hologic (HOLX) in Q4 2023, closing a stake of 18,200 shares — an estimated $1.26M sold.

PDT Partners first reported a position in HOLX in Q2 2013 and held it in 8 quarters. The position peaked at $22.8M in Q3 2015. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • PDT Partners reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 18,200 Hologic shares in Q4 2023, an estimated $1.26M.
  • PDT Partners first reported a position in Hologic in Q2 2013 and held it in 8 quarters.
  • PDT Partners's Hologic position peaked at $22.8M in Q3 2015.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.